SynX Pharma Inc. — Investor Relations & Filings
Filings indexed
21
across all filing types
Latest filing
2004-03-12
Regulatory Filings
Country
CA
Canada
Listing
TSX
SynX Pharma Inc. is a biotechnology firm specializing in the discovery, development, and commercialization of healthcare products and services, with a historical emphasis on medical diagnostics. The company's portfolio included proprietary in vitro diagnostic technology, notably an application utilizing glutamine synthetase as a marker for Alzheimer's disease. This diagnostic technology was previously licensed exclusively for human applications. SynX Pharma focuses on providing specialized diagnostic solutions within the healthcare sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2004-03-12 | English | |
| Material change report - English.pdf | 2003-07-14 | English | |
| Material change report - English.pdf | 2003-07-11 | English | |
| Material change report - English.pdf | 2002-10-16 | English | |
| Other material contract(s).pdf | 2001-09-06 | English | |
| Final Receipt.PDF | 2001-07-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2004
1 filing
| |||||
| 47832712 | Material change report - English.pdf | 2004-03-12 | English | ||
|
2003
2 filings
| |||||
| 47832714 | Material change report - English.pdf | 2003-07-14 | English | ||
| 47832782 | Material change report - English.pdf | 2003-07-11 | English | ||
|
2002
1 filing
| |||||
| 47832785 | Material change report - English.pdf | 2002-10-16 | English | ||
|
2001
6 filings
| |||||
| 47832788 | Other material contract(s).pdf | 2001-09-06 | English | ||
| 47832819 | Final Receipt.PDF | 2001-07-19 | English | ||
| 47832822 | Other material contract(s).pdf | 2001-07-19 | English | ||
| 47832830 | Preliminary Receipt.PDF | 2001-06-06 | English | ||
| 47832833 | Preliminary long form prospectus - English.pdf | 2001-06-06 | English | ||
| 47832861 | Material change report - English.pdf | 2001-05-09 | English | ||
|
2000
5 filings
| |||||
| 47832864 | Final Receipt.pdf | 2000-11-02 | English | ||
| 47832867 | Final long form prospectus - English.pdf | 2000-11-01 | English | ||
| 47832875 | Preliminary Receipt.PDF | 2000-10-04 | English | ||
| 47832921 | Preliminary long form prospectus - English.pdf | 2000-10-03 | English | ||
| 47832923 | Material change report - English.pdf | 2000-08-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CAPRICOR THERAPEUTICS, INC.
A clinical-stage biotech developing cell and exosome-based …
|
CAPR | US | Manufacturing |
|
Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines …
|
— | GB | Manufacturing |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and ant…
|
CRDL | CA | Manufacturing |
|
CAREGEN CO.,LTD.
Develops biomimetic peptides and growth factors for aesthet…
|
214370 | KR | Manufacturing |
|
Caribou Biosciences, Inc.
Clinical-stage biopharma developing genome-edited allogenei…
|
CRBU | US | Manufacturing |
|
Carisma Therapeutics Inc.
A clinical-stage biotech developing engineered macrophage-b…
|
CARM | US | Manufacturing |
|
Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase i…
|
4572 | JP | Manufacturing |
|
CARsgen Therapeutics Holdings Limited
Clinical-stage biopharma focused on developing innovative C…
|
2171 | HK | Manufacturing |
|
Cartesian Therapeutics, Inc.
A clinical-stage company developing mRNA-engineered cell th…
|
RNAC | US | Manufacturing |
|
CASI Pharmaceuticals, Inc.
Biopharmaceutical firm developing therapeutics for organ tr…
|
CASI | US | Manufacturing |
SynX Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44618/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44618 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44618 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44618 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44618}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SynX Pharma Inc. (id: 44618)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.